Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease

Eur Respir J. 2017 Oct 26;50(4):1701658. doi: 10.1183/13993003.01658-2017. Print 2017 Oct.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Biomarkers, Tumor
  • Carcinoma, Large Cell
  • Carcinoma, Neuroendocrine*
  • Carcinoma, Non-Small-Cell Lung*
  • Humans
  • Immunohistochemistry
  • Lung Neoplasms

Substances

  • Biomarkers, Tumor